YPrime Named 2024 Trailblazer in Patient Engagement.
YPrime has been named a 2024 Trailblazer in Patient Engagement by the Everest Group, a recognition that underscores our leadership in transforming patient experiences in clinical trials. This award reflects our commitment to integrating patient perspectives throughout clinical trials, enhancing collaboration among researchers, sponsors, and patients. By championing a patient-centric approach, our focus remains on innovation that delivers measurable benefits and improves healthcare outcomes worldwide.
Why YPrime Leads in Patient Engagement.
At YPrime, we understand that patient engagement is essential
for the success of clinical trials.
Our innovative electronic clinical outcome assessment (eCOA) technology is designed
to streamline patient participation, helping patients and clinical sites stay engaged
throughout their trial journey. Here’s how:
Faster Trial Startup for Better Outcomes.
Our eCOA platform helps sponsors launch trials 47% faster.
This saves you time for what matters most—improving patient care and collecting quality data. By reducing the friction in trial startup, we help clinical teams focus on delivering superior patient experiences and driving actionable insights.
What’s Inside the Everest Report?
The Everest Report underscores the growing significance of patient participation in clinical development within the life sciences field.
By incorporating the patient voice into clinical technology, and including patients in all stages of a clinical trial, we can transform treatment development, speed up time to market, and provide life-changing therapies that genuinely meet patient needs.
This report showcases how YPrime is setting the benchmark for patient engagement in clinical trials, and dives deep into innovative technologies that improve patient participation and experience.
A Glimpse at What the Everest Group Says About YPrime.
“YPrime’s commitment to building patient-centric, user-intuitive solutions has earned them the title of 2024 Trailblazer in Patient Engagement in Everest Group’s Clinical Trial Patient Engagement Assessment.”
— Nisarg Shah, Practice Director, Everest Group
At YPrime, we are dedicated to transforming patient engagement with our cutting-edge eCOA technology. By prioritizing patient experiences and encouraging active participation, we’re setting the stage for more effective and meaningful clinical trials, ultimately leading to advancements in healthcare and better patient outcomes.
To learn more about our industry-leading eCOA, visit www.yprime.com/ecoa